CLINICAL_TRIALS
trial_result
· 2017-01-04
Clinical Trial Update: Impact of SC vs IM Administration of DENVax (TDV) on Safety and Immunogenicity [Phase 1]
Summary
Phase 1 trial comparing subcutaneous vs intramuscular administration of DENVax (TDV) focusing on safety and immunogenicity in dengue fever.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Dengue Fever | Phase 1 | Status: COMPLETED | Results posted: 2017-01-04